Matrine targeted Src, inhibited its kinase activity and tyrosine phosphorylation to inhibit the proliferation of cancer cells by down-regulating the downstream MAPK/ERK, JAK2/STAT3, and PI3K/Akt phosphorylation signaling pathways (Fig. 7). The gene discussed is MAPK1; the disease is cancer.